Concentra Q1 revenue $500.8M (+7.1% YoY), Adj. EBITDA $102.7M (+6.8%), raises 2025 guidance

Concentra Group Holdings Parent, Inc.

2025-Q1 EPS reported $0.30 revenue$500,752,000

Net income $40.6M ($0.30 EPS); adjusted EPS $0.32, down from $0.49 YoY due to higher interest from IPO recap.
Closed $265M Nova Medical Centers acquisition (67 centers); signed $55M deal for Pivot Onsite Innovations (~200 clinics).
Declared $0.0625/share cash dividend, payable May 29; record date May 20.
FY2025 guidance raised: revenue $2.1-2.15B, Adj. EBITDA $415-430M; net leverage target ~3.5x.
Patient visits per day up 3.2% YoY; total centers 627 (vs 547 a year ago).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.